Mental health studies with practical context.

This study evaluated the safety of GM-1020 for people with depression.

Α Randomized, Two-way, Two-treatment, Two-period, Crossover, Open Label, Laboratory-blind, Comparative Bioavailability Study at Steady State Between Paliperidone 100 mg Prolonged Release Suspension for Injection (Test Product) and Xeplion® 100 mg Prolonged Release Suspension for Injection (Reference Product) Following Multiple Intramuscular Injections (Five Doses in Each Period, One Dose Every 28 Days) Administration to Patients With Schizophrenia Who Are Already Receiving a Stable Regimen of Paliperidone Prolonged Release Suspension Via The Intramuscular Route

Researchers are studying SEP-363856, tracking side effects to assess safety and tolerability in people with schizophrenia.

A Phase 1a, Randomized, Double-Blind, Placebo-Controlled, Single Center Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CS-1103 Following Single, Ascending Intravenous Dose Administration in Healthy Participants

An Open-Label Positron Emission Tomography Study to Investigate the Effect of Adjunctive Administration of SEP-363856 on Brain Dopamine Synthesis Capacity Using 18F-DOPA in Adult Subjects With Schizophrenia

A Randomized, Single-dose, Crossover Study of the Effects of SEP-363856 on Electrocardiogram (ECG) Intervals in Subjects With Schizophrenia

A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate SEP-363856 Physical Dependence in Adult Subjects With Schizophrenia

Researchers compared SEP-4199 200 mg, SEP-4199 400 mg and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

A single blind randomised controlled clinical trial testing the effectiveness of a clinical psychology intervention on improving the distress associated with auditory hallucinations in schizophrenia as measured by the Revised Beliefs About Voices Questionnaire.

A single blind randomised controlled clinical trial comparing a supported employment linkage intervention to treatment as usual on work and clinical outcomes in chronic schizophrenia.

An open-label clinical trial assessing the feasibility of FD-202 for managing anxiety and evaluating quality of life in adults with autism.

A randomised single blind trial comparing more time intensive therapy with experienced alcohol and drug nurse clinicians to a Brief Information Pack and matched time with a Brief Information Pack and general conversation with student nurse on engaging patients on a Mental Health Unit with mental illness and substance use disorder in the external rehabilitation service of their choice and decreasing psychiatric symptoms and substance use.